Lv1
60 积分 2026-04-15 加入
POS0541 Effect of Ivarmacitinib on patient-reported outcomes in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: a post hoc analysis of a phase III trial
2个月前
已关闭
POS0640 OLOKIZUMAB IMPROVED PATIENT REPORTED OUTCOMES IN MTX AND TNF INCOMPLETE RESPONDER RHEUMATOID ARTHRITIS PATIENTS: RESULTS FROM THE LONG TERM EXTENTION TRIAL
2个月前
已关闭
P127 Baricitinib Efficacy in Moderate Rheumatoid Arthritis - A Post-hoc Analysis from two Phase III Trials
2个月前
已完结
THU0167 ASSOCIATIONS BETWEEN RHEUMATOID ARTHRITIS DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN SARILUMAB CLINICAL TRIALS
2个月前
已完结
ABS0489 EFFICACY OF IVARMACITINIB IN BIOLOGICAL DMARDS-NAÏVE RHEUMATOID ARTHRITIS PATIENTS: A POST-HOC ANALYSIS FROM A PHASE III TRIAL
2个月前
已关闭
皖公网安备34019202002308
